Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study.

Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F.

J Appl Clin Med Phys. 2006 Winter;7(1):86-96. Epub 2006 Feb 15.

PMID:
16518320
2.

Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo.

Singhal A, Nagarajan R, Hinkin CH, Kumar R, Sayre J, Elderkin-Thompson V, Huda A, Gupta RK, Han SH, Thomas MA.

J Magn Reson Imaging. 2010 Jul;32(1):35-43. doi: 10.1002/jmri.22216.

PMID:
20578008
3.
4.

MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.

Taylor-Robinson SD, Sargentoni J, Oatridge A, Bryant DJ, Hajnal JV, Marcus CD, Seery JP, Hodgson HJ, deSouza NM.

Metab Brain Dis. 1996 Sep;11(3):249-68.

PMID:
8869945
5.

Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

Mínguez B, García-Pagán JC, Bosch J, Turnes J, Alonso J, Rovira A, Córdoba J.

Hepatology. 2006 Apr;43(4):707-14.

PMID:
16557541
6.

1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.

Miese F, Kircheis G, Wittsack HJ, Wenserski F, Hemker J, Mödder U, Häussinger D, Cohnen M.

AJNR Am J Neuroradiol. 2006 May;27(5):1019-26.

7.

Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy.

Haseler LJ, Sibbitt WL Jr, Mojtahedzadeh HN, Reddy S, Agarwal VP, McCarthy DM.

AJNR Am J Neuroradiol. 1998 Oct;19(9):1681-6.

8.

Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy.

Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, Green M, Han S, Thomas MA.

J Magn Reson Imaging. 2005 Apr;21(4):398-405.

PMID:
15779041
9.

MR imaging findings in hepatic encephalopathy.

Rovira A, Alonso J, Córdoba J.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1612-21. doi: 10.3174/ajnr.A1139. Epub 2008 Jun 26. Review.

10.

Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

Rovira A, Grivé E, Pedraza S, Rovira A, Alonso J.

AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1137-42.

11.

MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.

Tarasów E, Panasiuk A, Siergiejczyk L, Orzechowska-Bobkiewicz A, Lewszuk A, Walecki J, Prokopowicz D.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2149-53.

PMID:
14696484
12.

Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy.

Huda A, Guze BH, Thomas A, Bugbee M, Fairbanks L, Strouse T, Fawzy FI.

Psychosom Med. 1998 Sep-Oct;60(5):550-6.

PMID:
9773757
13.

Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy.

Catafau AM, Kulisevsky J, Bernà L, Pujol J, Martin JC, Otermin P, Balanzó J, Carrió I.

J Nucl Med. 2000 Mar;41(3):405-10.

14.

Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study.

Poveda MJ, Bernabeu A, Concepción L, Roa E, de Madaria E, Zapater P, Pérez-Mateo M, Jover R.

Neuroimage. 2010 Aug 15;52(2):481-7. doi: 10.1016/j.neuroimage.2010.04.260. Epub 2010 May 6.

PMID:
20451628
15.

Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.

Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e111-9. Epub 2007 Oct 9.

PMID:
17924951
16.

Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.

Geissler A, Lock G, Fründ R, Held P, Hollerbach S, Andus T, Schölmerich J, Feuerbach S, Holstege A.

Hepatology. 1997 Jan;25(1):48-54.

PMID:
8985263
17.

[Cerebral magnetic resonance spectroscopy in patients with hepatic encephalopathy: analysis before and after liver transplantation].

Schulz GJ, Coelho JC, Matias JE, Campos AC, Schulz DD, Bertoldi GA.

Rev Assoc Med Bras. 2009 Jan-Feb;55(1):35-9. Portuguese.

18.

In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.

Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK.

Liver Int. 2008 Sep;28(8):1095-103. doi: 10.1111/j.1478-3231.2007.01648.x. Epub 2008 Feb 8.

PMID:
18266634
19.

MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.

Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, Kaiser S, Mader I, Mayer J, Lauchart W, Gregor M, Voigt K.

Radiology. 2000 Sep;216(3):683-91.

PMID:
10966695
20.

Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis.

Laubenberger J, Häussinger D, Bayer S, Gufler H, Hennig J, Langer M.

Gastroenterology. 1997 May;112(5):1610-6.

PMID:
9136840
Items per page

Supplemental Content

Write to the Help Desk